Showing results (1-10 of 676) with videos related to
Sort By:
Pageof 68
Trends in Pharmacological Sciences|June 25, 2013
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disordersMathias Buttmann, Srini Kaveri, Hans-Peter HartungMonoclonal Antibodies in Immunodiagnosis and Immunotherapy|January 29, 2021
How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network ModelHeinz Kohler, Srini KaveriExpert Review of Neurotherapeutics|April 28, 2010
Treating multiple sclerosis with monoclonal antibodies: a 2010 updateMathias ButtmannAdvances in Experimental Medicine and Biology|August 21, 2012
Multi-faceted role of naturally occurring autoantibodies in fighting pathogensHicham Bouhlal, Srini KaveriExpert Review of Neurotherapeutics|March 19, 2008
Treating multiple sclerosis with monoclonal antibodiesMathias Buttmann, Peter RieckmannJournal of Neurology|September 20, 2008
Advances in the understanding of the mechanism of action of IVIgHans-Peter HartungNeurology(R) Neuroimmunology & Neuroinflammation|June 7, 2020
Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MSHans-Peter Hartung, Expert Opinion on Pharmacotherapy|February 25, 2009
High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosisHans-Peter HartungJournal of Neurology|September 20, 2005
Early treatment and dose optimisation BENEFIT and BEYONDHans-Peter HartungMMW Fortschritte Der Medizin|January 29, 2010
[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis]Mathias Buttmann, Peter RieckmannPageof 68